Acute Lymphoblastic Leukemia(T-ALL)-09
A university student named Mengmeng from Yanjiao, Guizhou, received effective treatment at BIOOCUS Medical Group .
Mengmeng, female, 21 years old, presented to our outpatient clinic on June 22, 2021, with persistent fatigue. Blood routine test showed WBC 479×10^9/L. Further bone marrow examinations confirmed acute lymphoblastic leukemia (T-cell subtype). She underwent two cycles of chemotherapy, but leukemia remained unresponsive, with MRD (minimal residual disease) at 56.01%, and she also had central nervous system leukemia involvement.
On August 13, autologous lymphocytes were collected and chemotherapy was administered. On August 30, Mengmeng received CD7 CAR-T cell infusion. Two weeks after infusion, bone marrow examination showed complete remission, MRD negativity, and control of central nervous system leukemia. She experienced a grade 1 cytokine release syndrome (CRS) reaction with no central nervous system adverse reactions.
description2
